Trump picks Dr. Heidi Overton as his FDA nominee : NPR
Key Points:
- President Trump has nominated Dr. Heidi Overton, a surgeon and current deputy assistant to the president for domestic policy, to be the next FDA commissioner, filling the vacancy left by Dr. Marty Makary's resignation in May.
- Dr. Joshua Sharfstein, former principal deputy commissioner at the FDA, noted that transitioning from the White House to the FDA can be challenging due to the agency's complex responsibilities and pressures from political, business, and advocacy groups.
- Overton has previously opposed gender-affirming care for minors and questioned the safety of medication abortion, and she supported Trump's controversial executive order seeking changes to the childhood vaccine schedule, including separating the MMR vaccine into individual shots.
- Public health experts warn that separating the MMR vaccine lacks scientific support and could increase costs and the risk of missed doses, raising concerns about Overton's stance on vaccine policy.
- Overton's nomination requires Senate confirmation, with notable opposition from Sen. Patty Murray and expressed concerns from Sen. Bill Cassidy, indicating a potentially contentious confirmation process.